CASI Pharmaceuticals (CASIF) Treasury Shares (2020 - 2025)

CASI Pharmaceuticals has reported Treasury Shares for 5 years, with the latest figure at $9.6 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $9.6 million; the trailing twelve-month figure through Dec 2025 stood at $9.6 million (changed 0.0% YoY), and the FY2025 full-year result was $9.6 million, changed 0.0% from the prior year.
• Treasury Shares for Q4 2025 stood at $9.6 million, up from -$9.6 million in the prior quarter.
• The five-year high for Treasury Shares was $3.7 million in Q1 2022, with the low at $411952.0 in Q4 2023.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.0 million in 2025.
• Annual changes were most pronounced in 2024 — Treasury Shares changed 0.0% — and 2025, when it surged 99.9%.
• CASI Pharmaceuticals' Treasury Shares stood at $8.0 million in 2021, then rose by 16.13% to $9.3 million in 2022, then grew by 2.94% to $9.6 million in 2023, then changed by 0.0% to $9.6 million in 2024, then changed by 0.0% to $9.6 million in 2025.
• The last three Treasury Shares figures came in at $9.6 million (Q4 2025), -$9.6 million (Q3 2025), and -$9.6 million (Q2 2025), per Business Quant data.